Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 44

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 44
---
 ● | success of our competitors in developing or commercializing products; |

| ● | ability to commercialize or obtain regulatory approvals for our product, or delays in commercializing or obtaining regulatory approvals; |

| ● | strategic transactions undertaken by us; |

| ● | additions or departures of key personnel; |

| ● | prevailing economic conditions; |

| ● | disputes concerning our intellectual property or other proprietary rights; |

| ● | FDA or other U.S. or foreign regulatory actions affecting us or the pharmaceutical industry; |

| ● | sales of our common stock by our officers, directors or significant stockholders; |

<div align='center'>22</div>

| ● | future sales or issuances of equity or debt securities by us; |

| ● | business disruptions caused by earthquakes, fires or other natural disasters; |

| ● | the exercise and sale of any outstanding warrants or options, including the exercise of the Warrants issued in this offering; |

| ● | changes in our Board or management; |

| ● | issuance of new or changed securities analysts’ reports or recommendations regarding us; |

| ● | any future COVID-19 outbreaks; |

| ● | changes in our capital structure, such as future issuances of debt or equity securities; |

| ● | short sales, hedging and other derivative transactions involving our capital stock; and |

| ● | general economic and geopolitical conditions. |

In addition, if the market for stocks in our industry
or the stock market, in general, experiences a loss of investor confidence, the trading price of our common stock could decline for reasons
unrelated to our business, results of operations or financial condition. The trading price of our common stock might also decline in reaction
to events that affect other companies in our industry even if these events do not directly affect us. In the past, following periods of
volatility in the market price of a company’s securities, securities class action litigation has often been brought against that
company. If our stock price is volatile, we may become the target of securities litigation. Securities litigation could result in substantial
costs and divert our management’s attention and resources from our business. This could have a material adverse effect on our business,
results of operations, and financial condition.

We may not be able to maintain the listing of our common stock on Nasdaq, which could adversely affect our liquidity and the trading volume and market price of our common stock and decrease or eliminate your investment.

Our common stock is listed on The Nasdaq Capital Market. If we violate